3D Cell Culture Market Size, Share, and Trends 2024 to 2034

The global 3D cell culture market size was USD 1.62 billion in 2023, calculated at USD 1.86 billion in 2024 and is projected to surpass around USD 7.06 billion by 2034, expanding at a CAGR of 14.3% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 3012
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on 3D Cell Culture Market 

5.1. COVID-19 Landscape: 3D Cell Culture Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global 3D Cell Culture Market, By Type

8.1. 3D Cell Culture Market, by Type, 2024-2034

8.1.1 Scaffold-based 3D Cell Cultures

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Scaffold-free 3D Cell Cultures

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Microfluidics

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Bioreactors

8.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global 3D Cell Culture Market, By Application

9.1. 3D Cell Culture Market, by Application, 2024-2034

9.1.1. Cancer

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Tissue Engineering & Immunohistochemistry

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Drug Development

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Stem Cell Research

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global 3D Cell Culture Market, By End-Use

10.1. 3D Cell Culture Market, by March, 2024-2034

10.1.1. Biotechnology and Pharmaceutical Industries

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Research Laboratories and Institutes

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Hospitals and Diagnostic Centers

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global 3D Cell Culture Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Type (2021-2034)

11.1.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.4.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.5.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.4.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.5.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.6.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.7.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.4.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.5.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.6.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.7.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.4.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.5.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.6.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.7.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.4.3. Market Revenue and Forecast, by End-Use(2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.5.3. Market Revenue and Forecast, by End-Use(2021-2034)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Merck KGaA

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Corning Incorporated

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Lonza

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. PELOBIOTECH GmbH

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Iwai North America Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Lena Biosciences

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. REPROCELL Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Synthecon

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. InSphero AG

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client